12/14/2011 Nu Skin Enterprises Acquires LifeGen Technologies
10/21/2010 - LifeGen Technologies awarded Phase I SBIR grant from the National Institute on Aging
More information here
10/22/2009 - Nu Skin signs Research Agreement with LifeGen Technologies
LifeGen Co-founder Richard Weindruch featured on CBS's 60 Minutes news story on resveratrol and calorie
1/25/2009 Link to story and video
LifeGen researchers report that consumption of a low dose of the red wine molecule resveratrol mimics the gene
expression profile of mice subjected to a calorie-restricted diet.
6/4/2008 - PLoS ONE
LifeGen Technologies is a genomics company that focuses on gene expression profiling as it relates to the aging process.
Our mission at LifeGen Technologies is to discover the genetic basis of the aging process with the goal of increasing the healthy life span of humans and animals.
LifeGen Technologies, LLC is a Madison, Wisconsin-based genomics company that is focusing on gene expression analysis as it relates to the aging process of humans and animals. LifeGen’s pioneering research has resulted in several pending patents, and on-going research is expected to yield additional, important intellectual property. Accordingly, LifeGen Technologies is strategically positioned to serve as a valuable partner to other companies involved in drug development and in animal and human nutraceuticals.
Identification of tissue-specific transcriptional markers of caloric restriction in the mouse and their use to evaluate caloric restriction mimetics (Aging Cell. 2017)
Caloric restriction delays disease onset and mortality in rhesus monkeys (Science. 2009)
Gene expression profiling of aging in multiple mouse strains: identification of aging biomarkers and impact of dietary antioxidants (Aging Cell. 2009)
Short-term consumption of a resveratrol-containing nutraceutical mixture mimics gene expression of long-term caloric restriction in mouse heart
(Experimental Gerontology 2008)